Home/Alkeus Pharmaceuticals/Michel Dahan

MD

Michel Dahan

President and Chief Executive Officer

Alkeus Pharmaceuticals

Therapeutic Areas

Ophthalmology Rare Disease

Alkeus Pharmaceuticals Pipeline

Drug	Indication	Phase
Gildeuretinol (ALK-001)	Stargardt disease	Phase 3

Leadership Team at Alkeus Pharmaceuticals

David Arkowitz, M.B.A.

Chief Financial Officer

View full Alkeus Pharmaceuticals profile